Company profile: Genesis Therapeutics
1.1 - Company Overview
Company description
- Provider of AI-enabled small molecule drug discovery solutions, including GEMS for generative and predictive design of novel and challenging targets; Dynamic PotentialNet for potency and ADMET prediction using deep learning and molecular simulations; a Molecular Generation Engine to explore chemical space; and AI platform collaborations with Eli Lilly and Genentech.
Products and services
- Dynamic PotentialNet: A proprietary deep learning technology predicting molecular properties—including potency and ADMET—using molecular simulations and neural models for accurate property estimation
- GEMS: A generative-predictive AI platform used for small molecule drug discovery, focusing development on novel and challenging targets to accelerate medicine discovery
- Molecular Generation Engine: An AI-guided engine enabling exploration of chemical space to identify molecules for drug discovery, particularly for difficult targets
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genesis Therapeutics
Genedata
HQ: Switzerland
Website
- Description: Provider of bioinformatics software and scientific consulting services for drug discovery and life sciences, delivering platforms for biopharma R&D digitalization, screening data analysis, NGS-based cell line development and biosafety, biologics bioprocess design, mass spectrometry–based biotherapeutic characterization and quality monitoring, and multi-omics, biomarker, and clinical data integration for precision medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genedata company profile →
Insilico Biotechnology
HQ: Germany
Website
- Description: Provider of bioprocess software and services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Insilico Biotechnology company profile →
Zageno
HQ: United States
Website
- Description: Provider of an enterprise marketplace connecting e-commerce to life science, offering an online platform to compare and procure lab supplies from various brands, procurement solutions including invoice consolidation and streamlined vendor setup, and a product selection and ordering platform with detailed information, pricing, and availability.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zageno company profile →
Axiom Metrics
HQ: Canada
Website
- Description: Provider of e-clinical, EDC, and data management solutions and services for life science organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axiom Metrics company profile →
Warp Drive Bio
HQ: United States
Website
- Description: Provider of a proprietary genomic search engine and customized search queries that reveal hidden natural products on the basis of their distinctive genomic signature.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Warp Drive Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genesis Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genesis Therapeutics
2.2 - Growth funds investing in similar companies to Genesis Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genesis Therapeutics
4.2 - Public trading comparable groups for Genesis Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →